Former R1 RCM chief named Xsolis CEO

Advertisement

Xsolis, which develops AI-driven technology for mid-revenue cycle management, has named Lee Rivas as CEO.

He succeeds co-founder Joan Butters, effective immediately, according to an Oct. 27 Xsolis news release. Ms. Butters has led the company since 2013. 

Mr. Rivas previously served as CEO of R1 RCM from January 2023 until the company was taken private in November 2024. He had joined R1 in June 2022, following the company’s acquisition of revenue recovery provider and consultant Cloudmed. Mr. Rivas was Cloudmed’s CEO.

“I am excited to join Xsolis at this important stage in the company’s evolution,” Mr. Rivas said in the release. “This team has spent years taking friction out of the work between hospitals and health plans and has earned the trust of some of the most important health systems in the country. I am looking forward to what comes next.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Revenue Cycle Management

Advertisement